Mediterranean vs. High-Fermented-Food Diet Adherence on Inflammation in Lupus
NCT05379725 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5
Last updated 2025-06-26
Summary
This is a 4-month randomized controlled trial to evaluate the feasibility of 'good and very good' adherence to the Mediterranean dietary pattern and to a high-fermented-food diet by individuals with Systemic lupus erythematosus (SLE).
Conditions
- Lupus Erythematosus, Systemic
Interventions
- OTHER
-
Mediterranean Dietary Pattern
The Mediterranean dietary pattern includes whole or minimally processed foods with a high intake of vegetables, fruits, whole grains, fish, and olive oil.
- OTHER
-
High Fermented Food Dietary Pattern
Fermented foods such as yogurt, kefir, fermented cottage cheese, fermented vegetables, vegetable brine drinks, kombucha, other fermented non-alcoholic drinks, and other foods will be recommended.
Sponsors & Collaborators
-
University of Florida
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-03-22
- Primary Completion
- 2025-03-01
- Completion
- 2025-03-01
Countries
- United States
Study Locations
More Related Trials
-
Effect of Curcumin on Systemic Lupus Erythematosus
NCT03953261 ·Status: TERMINATED ·Phase: PHASE2
-
Lupus Education Alliance Program
NCT05243875 ·Status: TERMINATED ·Phase: NA
-
Development of a Dietary Intervention Model Based on Genetic Data as an Implementation of a Healthy Lifestyle in the Management of Systemic Lupus Erythematosus Patients
NCT07183007 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Dietary Phytoestrogens as Risk Factors for Systemic Lupus Erythematosus
NCT03421184 ·Status: COMPLETED ·Phase: NA
-
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
NCT01405196 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
NCT01946880 ·Status: TERMINATED ·Phase: PHASE2
-
Prognostic Factors for Fatigue in Patients With Systemic Lupus Erythematosus
NCT07123220 ·Status: COMPLETED
-
Laser Puncture and Program of Lifestyle Modification in Lupus Females
NCT05381545 ·Status: UNKNOWN ·Phase: NA
-
Weaning of Immunosuppression in Nephritis of Lupus
NCT01284725 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Tolerability Study of MEDI-570 in Systemic Lupus Erythematosus
NCT01127321 ·Status: TERMINATED ·Phase: PHASE1
-
A Pilot Study to Explore the Role of Gut Flora in Lupus
NCT04213690 ·Status: WITHDRAWN
-
Associating Gastric Infection With Autoimmune Flare Severity in an Egyptians
NCT07157202 ·Status: NOT_YET_RECRUITING
-
Probiotics in Systemic Lupus Erythematosus
NCT05433857 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study - Effect of Omega-3 on Systemic Lupus Erythematosus
NCT02021513 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of an Intervention With EVOO and Physical Activity in Patients With Systemic Lupus Erythematosus
NCT05261529 ·Status: UNKNOWN ·Phase: NA
-
Role of PPAR-y Agonists in Immunomodulation and Vascular Prevention in SLE (PPAR-SLE)
NCT02338999 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Role of Lipids in Immune Cell Function in SLE Patients
NCT04361734 ·Status: UNKNOWN
-
Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment Optimization
NCT03142412 ·Status: UNKNOWN
-
Gradual Withdrawal of Low-dose Glucocorticoid in Clinically Quiescent Systemic Lupus Erythematosus.
NCT06234852 ·Status: COMPLETED ·Phase: NA
-
A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus
NCT03517722 ·Status: TERMINATED ·Phase: PHASE3
-
Leflunomide Versus Azathioprine for Maintenance Therapy of Lupus Nephritis
NCT01172002 ·Status: UNKNOWN ·Phase: NA
-
Reducing Disparities in Medication Adherence in SLE
NCT03738826 ·Status: COMPLETED ·Phase: NA
-
Fatigue in Systemic Lupus Erythematosus
NCT06652256 ·Status: COMPLETED
-
Fatigue in Lupus Intervention Programmes (FLIP)
NCT06308770 ·Status: RECRUITING ·Phase: NA
-
Balancing Lupus Experiences With Stress Strategies
NCT01351662 ·Status: COMPLETED ·Phase: PHASE1/PHASE2